Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? (Q35142942)

6 August 2017

1 reference

title

Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? (English)

1 reference

6 August 2017

1 reference

Gang Wei

1

1 reference

6 August 2017

Jonathan Moss

series ordinal

2

1 reference

6 August 2017

Chun Su Yuan

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

Biochemical Pharmacology

1 reference

6 August 2017

65

1 reference

6 August 2017

1761-1766

1 reference

6 August 2017

11

1 reference

Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Effect of Morphine on Resistance to Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Effects of morphine dependence on the pathogenesis of swine herpesvirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

7 January 2021

Opiates and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Infections resulting from narcotic addiction; report of 102 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

The Major Medical Complications of Heroin Addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Immunological analyses of peripheral leukocytes from workers at an ethical narcotics manufacturing facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Equianalgesic doses of subcutaneous but not intrathecal morphine alter phenotypic expression of cell surface markers and mitogen-induced proliferation in rat lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Altered T-lymphocyte subsets in hospitalized intravenous drug abusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Immunologic dysfunction in heroin addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Immunosuppressive effects of chronic morphine treatment in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Fas-mediated cell death promoted by opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Methadone enhances human immunodeficiency virus infection of human immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

The periaqueductal gray matter mediates opiate-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

In vivo autoradiography: Visualization of stress-induced changes in opiate receptor occupancy in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Effect of the opioid remifentanil on cellular immune response in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Mechanisms of conditioned immunomodulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Immunomodulatory effects of in vitro exposure to morphine and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Immunomodulatory activity of mu- and kappa-selective opioid agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Both T cells and macrophages are targets of kappa-opioid-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of kappa opioid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Selective postoperative inhibition of gastrointestinal opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

Selective postoperative inhibition of gastrointestinal opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900085-6

10.1016/S0006-2952(03)00085-6

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference